HSBC Holdings’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-39,213
Closed -$110K 2765
2025
Q2
$110K Buy
+39,213
New +$129K ﹤0.01% 2832
2023
Q2
Sell
-46,050
Closed -$39.1K 2583
2023
Q1
$39.1K Sell
46,050
-9,838
-18% -$10.8K ﹤0.01% 2580
2022
Q4
$50.8K Hold
55,888
﹤0.01% 2967
2022
Q3
$96K Sell
55,888
-8,754
-14% -$22.9K ﹤0.01% 2750
2022
Q2
$138K Buy
64,642
+38,477
+147% +$102K ﹤0.01% 2971
2022
Q1
$92K Buy
26,165
+35
+0.1% +$101 ﹤0.01% 3136
2021
Q4
$98K Buy
26,130
+15,800
+153% +$96.9K ﹤0.01% 3141
2021
Q3
$76K Sell
10,330
-1,470
-12% -$12.6K ﹤0.01% 2908
2021
Q2
$161K Buy
+11,800
New +$116K ﹤0.01% 2794

Other funds holding CLOV

HSBC Holdings's CLOV Position: Q3 2025 in Review

HSBC Holdings sold out of Clover Health Investments (CLOV) in Q3 2025, closing a stake of 39,213 shares — an estimated $110K sold.

HSBC Holdings first reported a position in CLOV in Q2 2021 and held it in 9 quarters. The position peaked at $161K in Q2 2021. 201 funds tracked by Wall St. Rank hold CLOV as of Q3 2025.

  • HSBC Holdings reported no remaining Clover Health Investments position as of Q3 2025 after selling out during the quarter.
  • HSBC Holdings sold 39,213 Clover Health Investments shares in Q3 2025, an estimated $110K.
  • HSBC Holdings first reported a position in Clover Health Investments in Q2 2021 and held it in 9 quarters.
  • HSBC Holdings's Clover Health Investments position peaked at $161K in Q2 2021.
  • 201 funds tracked by Wall St. Rank held Clover Health Investments as of Q3 2025.

Based on HSBC Holdings's 13F filing for Q3 2025, filed 13 Nov 2025.